Duality Advisers LP Purchases New Shares in Chemed Co. (NYSE:CHE)

Share on StockTwits

Duality Advisers LP bought a new stake in shares of Chemed Co. (NYSE:CHE) during the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 3,337 shares of the company’s stock, valued at approximately $1,505,000.

Other large investors have also made changes to their positions in the company. Harvest Fund Management Co. Ltd grew its position in Chemed by 28.0% in the first quarter. Harvest Fund Management Co. Ltd now owns 462 shares of the company’s stock worth $200,000 after acquiring an additional 101 shares in the last quarter. MML Investors Services LLC lifted its stake in shares of Chemed by 22.2% in the 1st quarter. MML Investors Services LLC now owns 1,077 shares of the company’s stock valued at $467,000 after purchasing an additional 196 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Chemed by 348.3% in the 1st quarter. Tower Research Capital LLC TRC now owns 130 shares of the company’s stock worth $57,000 after purchasing an additional 101 shares during the period. AXA raised its holdings in Chemed by 41.0% during the 1st quarter. AXA now owns 11,000 shares of the company’s stock valued at $4,765,000 after buying an additional 3,200 shares during the period. Finally, Franklin Resources Inc. lifted its position in Chemed by 14.7% in the first quarter. Franklin Resources Inc. now owns 11,039 shares of the company’s stock worth $4,782,000 after buying an additional 1,413 shares during the last quarter. 88.73% of the stock is owned by hedge funds and other institutional investors.

Shares of CHE opened at $492.19 on Friday. The firm has a market capitalization of $7.81 billion, a price-to-earnings ratio of 30.94, a PEG ratio of 3.07 and a beta of 0.70. The company has a debt-to-equity ratio of 0.14, a current ratio of 0.59 and a quick ratio of 0.78. Chemed Co. has a 1-year low of $330.01 and a 1-year high of $513.75. The company has a 50-day moving average of $462.10 and a 200 day moving average of $451.92.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, July 29th. The company reported $4.41 EPS for the quarter, topping the Zacks’ consensus estimate of $3.75 by $0.66. The business had revenue of $502.20 million for the quarter, compared to analyst estimates of $522.90 million. Chemed had a net margin of 12.99% and a return on equity of 36.71%. The company’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same period last year, the company posted $3.36 earnings per share. On average, equities analysts anticipate that Chemed Co. will post 15.98 earnings per share for the current fiscal year.

Separately, Zacks Investment Research raised shares of Chemed from a “hold” rating to a “buy” rating and set a $489.00 target price on the stock in a research note on Tuesday, May 19th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $509.80.

In other news, Director Donald E. Saunders sold 300 shares of the business’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $475.53, for a total value of $142,659.00. Following the completion of the sale, the director now owns 6,736 shares in the company, valued at approximately $3,203,170.08. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Naomi C. Dallob sold 2,200 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $430.00, for a total transaction of $946,000.00. Following the completion of the sale, the vice president now directly owns 2,347 shares of the company’s stock, valued at approximately $1,009,210. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 16,020 shares of company stock valued at $7,212,353. 3.96% of the stock is currently owned by corporate insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Recommended Story: Initial Coin Offerings entail a high degree of risk

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.

 

Latest News

Different Types of Research Papers
Different Types of Research Papers
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing


 
© 2006-2020 BBNS.